• Je něco špatně v tomto záznamu ?

Cooperation of augmented calcium sensitization and increased calcium entry contributes to high blood pressure in salt-sensitive Dahl rats

J. Zicha, M. Behuliak, A. Vavřínová, Z. Dobešová, J. Kuneš, H. Rauchová, I. Vaněčková

. 2021 ; 44 (9) : 1067-1078. [pub] 20210419

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012245
E-zdroje Online Plný text

NLK ProQuest Central od 2015-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2015-01-01 do Před 1 rokem

Salt hypertensive Dahl rats are characterized by sympathoexcitation and relative NO deficiency. We tested the hypothesis that the increased blood pressure (BP) response to fasudil in salt hypertensive Dahl rats is due to augmented calcium sensitization in the salt-sensitive strain and/or due to their decreased baroreflex efficiency. BP reduction after acute administration of nifedipine (an L-type voltage-dependent calcium channel blocker) or fasudil (a Rho kinase inhibitor) was studied in conscious intact rats and in rats subjected to acute NO synthase inhibition or combined blockade of the renin-angiotensin system (captopril), sympathetic nervous system (pentolinium), and NO synthase (L-NAME). Intact salt-sensitive (SS) Dahl rats fed a low-salt diet had greater BP responses to nifedipine (-31 ± 6 mmHg) or fasudil (-34 ± 7 mmHg) than salt-resistant (SR) Dahl rats (-16 ± 4 and -17 ± 2 mmHg, respectively), and a high-salt intake augmented the BP response only in SS rats. These BP responses were doubled after acute NO synthase inhibition, indicating that endogenous NO attenuates both calcium entry and calcium sensitization. Additional pentolinium administration, which minimized sympathetic compensation for the drug-induced BP reduction, magnified the BP responses to nifedipine or fasudil in all groups except for salt hypertensive SS rats due to their lower baroreflex efficiency. The BP response to the calcium channel blocker nifedipine can distinguish SS and SR rats even after calcium sensitization inhibition by fasudil, which was not seen when fasudil was administered to nifedipine-pretreated rats. Thus, enhanced calcium entry (potentiated by sympathoexcitation) in salt hypertensive Dahl rats is the abnormality that is essential for their BP increase, which was further augmented by increased calcium sensitization in salt-sensitive Dahl rats.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012245
003      
CZ-PrNML
005      
20220506130255.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41440-021-00659-5 $2 doi
035    __
$a (PubMed)33875859
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Josef.Zicha@fgu.cas.cz
245    10
$a Cooperation of augmented calcium sensitization and increased calcium entry contributes to high blood pressure in salt-sensitive Dahl rats / $c J. Zicha, M. Behuliak, A. Vavřínová, Z. Dobešová, J. Kuneš, H. Rauchová, I. Vaněčková
520    9_
$a Salt hypertensive Dahl rats are characterized by sympathoexcitation and relative NO deficiency. We tested the hypothesis that the increased blood pressure (BP) response to fasudil in salt hypertensive Dahl rats is due to augmented calcium sensitization in the salt-sensitive strain and/or due to their decreased baroreflex efficiency. BP reduction after acute administration of nifedipine (an L-type voltage-dependent calcium channel blocker) or fasudil (a Rho kinase inhibitor) was studied in conscious intact rats and in rats subjected to acute NO synthase inhibition or combined blockade of the renin-angiotensin system (captopril), sympathetic nervous system (pentolinium), and NO synthase (L-NAME). Intact salt-sensitive (SS) Dahl rats fed a low-salt diet had greater BP responses to nifedipine (-31 ± 6 mmHg) or fasudil (-34 ± 7 mmHg) than salt-resistant (SR) Dahl rats (-16 ± 4 and -17 ± 2 mmHg, respectively), and a high-salt intake augmented the BP response only in SS rats. These BP responses were doubled after acute NO synthase inhibition, indicating that endogenous NO attenuates both calcium entry and calcium sensitization. Additional pentolinium administration, which minimized sympathetic compensation for the drug-induced BP reduction, magnified the BP responses to nifedipine or fasudil in all groups except for salt hypertensive SS rats due to their lower baroreflex efficiency. The BP response to the calcium channel blocker nifedipine can distinguish SS and SR rats even after calcium sensitization inhibition by fasudil, which was not seen when fasudil was administered to nifedipine-pretreated rats. Thus, enhanced calcium entry (potentiated by sympathoexcitation) in salt hypertensive Dahl rats is the abnormality that is essential for their BP increase, which was further augmented by increased calcium sensitization in salt-sensitive Dahl rats.
650    _2
$a zvířata $7 D000818
650    _2
$a krevní tlak $7 D001794
650    _2
$a vápník $7 D002118
650    12
$a hypertenze $x farmakoterapie $7 D006973
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední Dahl $7 D020303
650    12
$a kuchyňská sůl $7 D017673
650    _2
$a vazokonstrikce $7 D014661
655    _2
$a časopisecké články $7 D016428
700    1_
$a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vavřínová, Anna $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Dobešová, Zdenka $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kuneš, Jaroslav $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Rauchová, Hana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Ivana.Vaneckova@fgu.cas.cz
773    0_
$w MED00006041 $t Hypertension research : official journal of the Japanese Society of Hypertension $x 1348-4214 $g Roč. 44, č. 9 (2021), s. 1067-1078
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33875859 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130247 $b ABA008
999    __
$a ok $b bmc $g 1789714 $s 1163446
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 44 $c 9 $d 1067-1078 $e 20210419 $i 1348-4214 $m Hypertension research $n Hypertens Res $x MED00006041
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...